About the book
Radiopharmaceuticals are special medicinal preparations containing radioisotopes which are used in many clinical areas for either diagnosis and/or therapy.
This book intends to provide the reader with a comprehensive overview of the current state-of-the-art in nuclear medicine's safety, featuring an easy-to-follow, vignette-based format that focuses on the most important evidence-based developments in tradiopharmaceuticals as important area in cancer therapy, bone metastasis, and neuroendocrinology tumours.
This book will aim to present the different methods for preparation, products evaluation, pharmacokinetics, biodistribution, and dose calculations. Moreover, new approaches will be discussed for new possible uses in both diagnosis and treatment to lessen the possible hazardous side effects. Basic, practical, and clinical applications will be presented in an easy and applied manner.
Interestingly, new techniques and new applications will be addresses especially in the area of the development of monoclonal antibodies (MoAbs) in radioscintigraphy of tumors. The use of nanostechnology enhance the efficacy of radiopharmaceuticals and improve the selectivity and pharmacokinetic properties.